Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 219

Similar articles for PubMed (Select 24590287)

1.

Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.

Daehn I, Casalena G, Zhang T, Shi S, Fenninger F, Barasch N, Yu L, D'Agati V, Schlondorff D, Kriz W, Haraldsson B, Bottinger EP.

J Clin Invest. 2014 Apr;124(4):1608-21. doi: 10.1172/JCI71195. Epub 2014 Mar 3.

2.

Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.

Lee HS.

Cell Tissue Res. 2012 Jan;347(1):129-40. doi: 10.1007/s00441-011-1169-7. Epub 2011 May 4. Review.

3.

Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis.

Finer G, Schnaper HW, Kanwar YS, Liang X, Lin HY, Hayashida T.

Kidney Int. 2012 Sep;82(5):525-36. doi: 10.1038/ki.2012.139. Epub 2012 Apr 25.

4.

Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.

Lee HS, Song CY.

Kidney Blood Press Res. 2010;33(1):24-9. doi: 10.1159/000285844. Epub 2010 Feb 23. Review.

PMID:
20185928
5.

Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.

Potla U, Ni J, Vadaparampil J, Yang G, Leventhal JS, Campbell KN, Chuang PY, Morozov A, He JC, D'Agati VD, Klotman PE, Kaufman L.

J Clin Invest. 2014 Apr;124(4):1757-69. doi: 10.1172/JCI67846. Epub 2014 Mar 18.

6.

HIV-associated nephropathy: experimental models.

Avila-Casado C, Fortoul TI, Chugh SS.

Contrib Nephrol. 2011;169:270-85. doi: 10.1159/000320212. Epub 2011 Jan 20.

PMID:
21252526
7.

Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.

Suzuki T, Matsusaka T, Nakayama M, Asano T, Watanabe T, Ichikawa I, Nagata M.

Am J Pathol. 2009 May;174(5):1675-82. doi: 10.2353/ajpath.2009.080789. Epub 2009 Apr 9. Erratum in: Am J Pathol. 2009 Sep;175(3):1349.

8.

Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro.

Casalena G, Krick S, Daehn I, Yu L, Ju W, Shi S, Tsai SY, D'Agati V, Lindenmeyer M, Cohen CD, Schlondorff D, Bottinger EP.

Am J Physiol Renal Physiol. 2014 Jun 1;306(11):F1372-80. doi: 10.1152/ajprenal.00608.2013. Epub 2014 Mar 5.

9.
10.

Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss.

Ueno T, Kobayashi N, Nakayama M, Takashima Y, Ohse T, Pastan I, Pippin JW, Shankland SJ, Uesugi N, Matsusaka T, Nagata M.

Kidney Int. 2013 Jun;83(6):1065-75. doi: 10.1038/ki.2013.48. Epub 2013 Feb 27.

PMID:
23447065
11.

Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis.

Kim JH, Kim BK, Moon KC, Hong HK, Lee HS.

Kidney Int. 2003 Nov;64(5):1715-21.

PMID:
14531804
12.

Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.

Fuchshofer R, Ullmann S, Zeilbeck LF, Baumann M, Junglas B, Tamm ER.

Histochem Cell Biol. 2011 Sep;136(3):301-19. doi: 10.1007/s00418-011-0844-9. Epub 2011 Aug 4.

PMID:
21814837
13.

Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis.

Pereira RL, Buscariollo BN, Corrêa-Costa M, Semedo P, Oliveira CD, Reis VO, Maquigussa E, Araújo RC, Braga TT, Soares MF, Moura IC, Malheiros DM, Filho AP, Keller AC, Câmara NO.

Kidney Int. 2011 Jun;79(11):1217-27. doi: 10.1038/ki.2011.14. Epub 2011 Mar 16.

PMID:
21412216
14.

Pathogenic role of TGF-β in the progression of podocyte diseases.

Lee HS.

Histol Histopathol. 2011 Jan;26(1):107-16. Review.

PMID:
21117032
15.

Pathobiology of focal segmental glomerulosclerosis: new developments.

D'Agati VD.

Curr Opin Nephrol Hypertens. 2012 May;21(3):243-50. doi: 10.1097/MNH.0b013e32835200df. Review.

PMID:
22357339
16.

Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.

Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, Liu Y.

J Am Soc Nephrol. 2009 Sep;20(9):1997-2008. doi: 10.1681/ASN.2009010019. Epub 2009 Jul 23.

17.

Gα12 activation in podocytes leads to cumulative changes in glomerular collagen expression, proteinuria and glomerulosclerosis.

Boucher I, Yu W, Beaudry S, Negoro H, Tran M, Pollak MR, Henderson JM, Denker BM.

Lab Invest. 2012 May;92(5):662-75. doi: 10.1038/labinvest.2011.198. Epub 2012 Jan 16.

18.

BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerization.

Li M, Armelloni S, Zennaro C, Wei C, Corbelli A, Ikehata M, Berra S, Giardino L, Mattinzoli D, Watanabe S, Agostoni C, Edefonti A, Reiser J, Messa P, Rastaldi MP.

J Pathol. 2015 Apr;235(5):731-44. doi: 10.1002/path.4484. Epub 2015 Jan 7.

PMID:
25408545
19.

CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.

Marshall CB, Krofft RD, Pippin JW, Shankland SJ.

Am J Physiol Renal Physiol. 2010 May;298(5):F1140-51. doi: 10.1152/ajprenal.00216.2009. Epub 2010 Feb 3.

20.

De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.

Ohse T, Vaughan MR, Kopp JB, Krofft RD, Marshall CB, Chang AM, Hudkins KL, Alpers CE, Pippin JW, Shankland SJ.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F702-11. doi: 10.1152/ajprenal.00428.2009. Epub 2009 Dec 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk